Pages that link to "Q36031839"
Jump to navigation
Jump to search
The following pages link to The clinical course of follicular lymphoma (Q36031839):
Displaying 15 items.
- Thyroid lymphoma: recent advances in diagnosis and optimal management strategies (Q26827420) (← links)
- Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL. (Q33412343) (← links)
- In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study (Q34194680) (← links)
- Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma. (Q35056309) (← links)
- T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells (Q35848840) (← links)
- The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma (Q36331576) (← links)
- Considerations in the initial management of follicular lymphoma (Q36724776) (← links)
- Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma (Q36726780) (← links)
- Follicular lymphoma of the thyroid gland (Q37169915) (← links)
- GM-CSF plus rituximab immunotherapy: translation of biologic mechanisms into therapy for indolent B-cell lymphomas. (Q37271831) (← links)
- Economic burden of follicular non-Hodgkin's lymphoma (Q37587999) (← links)
- The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium (Q38572605) (← links)
- Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkin lymphoma after responding to first-line rituximab plus chemotherapy (Q44033038) (← links)
- Multimodality imaging of indolent B cell lymphoma from diagnosis to transformation: what every radiologist should know (Q64111287) (← links)
- Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial (Q80166499) (← links)